Avior Wealth Management, LLC - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 72 filers reported holding HUMACYTE INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
Avior Wealth Management, LLC ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$2,930
+2.4%
1,0000.0%0.00%
Q2 2023$2,860
-7.4%
1,0000.0%0.00%
Q1 2023$3,090
+46.4%
1,0000.0%0.00%
Q4 2022$2,110
-29.7%
1,0000.0%0.00%
Q3 2022$3,0000.0%1,0000.0%0.00%
Q2 2022$3,000
-57.1%
1,0000.0%0.00%
-100.0%
Q1 2022$7,0000.0%1,0000.0%0.00%0.0%
Q4 2021$7,000
-36.4%
1,0000.0%0.00%0.0%
Q3 2021$11,0001,0000.00%
Other shareholders
HUMACYTE INC shareholders Q1 2022
NameSharesValueWeighting ↓
Imprint Wealth LLC 257,119$938,4120.62%
Endowment Wealth Management, Inc. 96,618$298,5500.30%
Prescott General Partners LLC 568,246$1,755,8800.14%
HAMILTON LANE ADVISORS LLC 52,693$1630.06%
United Asset Strategies, Inc. 58,960$182,1860.02%
Kovack Advisors, Inc. 35,000$108,1500.02%
Shay Capital LLC 19,987$61,7600.01%
Y-Intercept (Hong Kong) Ltd 14,565$45,0060.01%
Mendota Financial Group, LLC 500$3,5300.00%
PHILADELPHIA TRUST CO 10,000$310.00%
View complete list of HUMACYTE INC shareholders